STK11 and papillary serous cystadenocarcinoma: Evidence exists for its potential tumor suppressor role in EOC, including blocking epithelial-to-mesenchymal transition and apoptosis resistance in EOC cells [33], and LKB1 loss can induce papillary serous carcinoma when combined with other genetic mutations [34].